![April 2024 Labs in Court](https://www.g2intelligence.com/wp-content/uploads/2024/03/Apr24.LIA_.LabsinCourt.KL-DG-iStock-1387711606-1100x800-1-1080x675.jpg)
April 2024 Labs in Court
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Formulating queries that are compliant, informative, and effective—even in tricky situations.
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.
How clinical laboratory professionals can advocate for legislative and regulatory improvements
Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.
New molecular tests and diagnostic support technologies can help labs detect sepsis earlier, faster, and with greater accuracy
Clinical Microbiology division head Jeff Fuller, FCCM, discusses his clinical laboratory’s recent automation transformation and offers tips to ensure success
Key updates from the CDC’s new lab recommendations for syphilis testing.